Differentiated Thyroid Cancer and Brain Metastases

Feb 18, 2017 by in ONCOLOGY Comments Off on Differentiated Thyroid Cancer and Brain Metastases

Fig. 35.1 Computed tomography (CT) of the head. Arrow indicates a 3.4 cm hemorrhagic lesion extending into the right lateral ventricle with a low-density solid component, consistent with a hemorrhagic metastasis…

read more

RAI-Refractory Differentiated Thyroid Cancer and Lung Lesions Causing Bleeding

Feb 18, 2017 by in ONCOLOGY Comments Off on RAI-Refractory Differentiated Thyroid Cancer and Lung Lesions Causing Bleeding

© Springer International Publishing Switzerland 2016David S. Cooper and Cosimo Durante (eds.)Thyroid Cancer10.1007/978-3-319-22401-5_33 33. RAI-Refractory Differentiated Thyroid Cancer and Lung Lesions Causing Bleeding Steven I. Sherman1   (1) University of Texas MD Anderson Cancer Center, Unit 1461, 301402,…

read more

RAI-Refractory Differentiated Thyroid Cancer with Multiple Organ Progressive Disease

Feb 18, 2017 by in ONCOLOGY Comments Off on RAI-Refractory Differentiated Thyroid Cancer with Multiple Organ Progressive Disease

© Springer International Publishing Switzerland 2016David S. Cooper and Cosimo Durante (eds.)Thyroid Cancer10.1007/978-3-319-22401-5_32 32. RAI-Refractory Differentiated Thyroid Cancer with Multiple Organ Progressive Disease Steven I. Sherman1   (1) University of Texas MD Anderson Cancer Center, Unit 1461, 301402,…

read more

A Case of a Patient with Radioactive Iodine Refractory Differentiated Thyroid Cancer with Progressive Neck Disease (Latero-cervical Lymph Nodes) and Stable, Small Lung Metastases

Feb 18, 2017 by in ONCOLOGY Comments Off on A Case of a Patient with Radioactive Iodine Refractory Differentiated Thyroid Cancer with Progressive Neck Disease (Latero-cervical Lymph Nodes) and Stable, Small Lung Metastases

Fig. 30.1 Upper left: non-contrast-enhanced CT showing right paratracheal mass (white arrow). Lower left: 18FDG-PET-CT showing right paratracheal recurrent tumor (white arrow). Upper right: 18FDG uptake with a standard uptake…

read more

A Case of Papillary Thyroid Cancer Without Aggressive Histological Features with Nodal Metastases in an Older Patient

Feb 18, 2017 by in ONCOLOGY Comments Off on A Case of Papillary Thyroid Cancer Without Aggressive Histological Features with Nodal Metastases in an Older Patient

© Springer International Publishing Switzerland 2016David S. Cooper and Cosimo Durante (eds.)Thyroid Cancer10.1007/978-3-319-22401-5_23 23. A Case of Papillary Thyroid Cancer Without Aggressive Histological Features with Nodal Metastases in an Older Patient Maria Grazia Castagna1, 2, Lucia Brilli1, 2…

read more

A Case of Papillary Thyroid Cancer Without Aggressive Histological Features with Nodal Metastases Detected During Follow-Up in a Younger Patient

Feb 18, 2017 by in ONCOLOGY Comments Off on A Case of Papillary Thyroid Cancer Without Aggressive Histological Features with Nodal Metastases Detected During Follow-Up in a Younger Patient

© Springer International Publishing Switzerland 2016David S. Cooper and Cosimo Durante (eds.)Thyroid Cancer10.1007/978-3-319-22401-5_22 22. A Case of Papillary Thyroid Cancer Without Aggressive Histological Features with Nodal Metastases Detected During Follow-Up in a Younger Patient Maria Grazia Castagna1,…

read more

A Patient with Postsurgical Recurrent Laryngeal Nerve Damage and Nerve Monitoring

Feb 18, 2017 by in ONCOLOGY Comments Off on A Patient with Postsurgical Recurrent Laryngeal Nerve Damage and Nerve Monitoring

© Springer International Publishing Switzerland 2016David S. Cooper and Cosimo Durante (eds.)Thyroid Cancer10.1007/978-3-319-22401-5_21 21. A Patient with Postsurgical Recurrent Laryngeal Nerve Damage and Nerve Monitoring David L. Steward1   and Adam D. Goodale1   (1) Department of Otolaryngology – Head &…

read more

A Case with Postsurgical Hypoparathyroidism

Feb 18, 2017 by in ONCOLOGY Comments Off on A Case with Postsurgical Hypoparathyroidism

-hydroxylated vitamin D analogues, most patients with hypoparathyroidism have been shifted to treatment with either alfacalcidol or calcitriol, as the plasma half-life of activated vitamin D metabolites is much shorter…

read more
Get Clinical Tree app for offline access